This site uses cookies to collect statistics and improve your experience. By continuing to navigate you accept its use. View more


The Project

This project will commercialise novel and fast antibiotic susceptibility tests (AST) based on flow cytometric analysis, to determine antibiotic susceptibility of Gram-positive and Gram-negative bacteria. The novel flow cytometry antimicrobial susceptibility FAST-bact test delivers very fast results (within 1h) when compared to the current state-of-the art AST methods that have a turnaround time of at least 24 hours. The introduction of the FAST-bact tests will have an important impact on clinical decision-making for treatment of serious bacterial infections. It will help the physician to rapidly determine the microorganism phenotype and to initiate the optimal antibiotic treatment with the narrowest spectrum within the hour.


In this three-year project the novel FAST-bact tests will be finalised for commercialisation, including clinical validation, in five work packages.

Work Plan 1

In WP1 FASTinov and SERMAS perform the clinical validation in a real-life setting against the current standard methods, as developed by EUCAST and CLSI, on a large number of clinical samples and isolated strains. Profess Medical Consultancy will assist in study design and monitoring.

Work Plan 2

In WP2 μRoboptics will finalise the accompanying software package to deliver the final product for clinical use. The existing prototypes provide the start-point for this task. The software will be used additionally for analysis of all validation data generated in WP1, by FASTinov, assisted by μRoboptics and Profess.

Work Plan 3

In WP3 conditions for large scale production will be set up by EuroClone Diagnostics, and quality control will be performed.

Work Plan 4

The final steps to the market will be facilitated establishing the commercialisation strategy and drafting of a dissemination plan by FASTinov in WP4.


The overall coordination of the project will be performed within WP5 by FASTinov, to ensure that all project objectives and timelines are met.

Funded by the Horizon 2020 framework programme of the European Union